London, UK, 7 March 2007: BioProgress plc (‘BioProgress’ or the ‘Company’) (AIM: BPRG; NASDAQ: BPRG), the specialty pharmaceutical and healthcare company, is pleased to announce the completion of an agreement with Tiber Laboratories to promote the Accuhist® line of pediatric drops throughout the United States.
